ROC1 promotes the malignant progression of bladder cancer by regulating p-IkappaBalpha/NF-kappaB signaling.
Wu Q, Zhou X, Li P, Ding M, You S, Xu Z, Ye J, Chen X, Tan M, Wang J, Wang W, Qiu J.
J Exp Clin Cancer Res. 2021 May 7;40(1):158. doi: 10.1186/s13046-021-01935-5.
Metastatic urothelial carcinoma.
Knowles M, Dyrskjøt L, Heath EI, Bellmunt J, Siefker-Radtke AO.
Cancer Cell. 2021 May 10;39(5):583-585. doi: 10.1016/j.ccell.2021.04.012.
Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall.
Feldman A, Borak S, Rais-Bahrami S, Gordetsky J.
Int J Surg Pathol. 2018 Apr;26(2):120-125. doi: 10.1177/1066896917741550. Epub 2017 Nov 23.
Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream.
Engilbertsson H, Aaltonen KE, Björnsson S, Kristmundsson T, Patschan O, Rydén L, Gudjonsson S.
J Urol. 2015 Jan;193(1):53-7. doi: 10.1016/j.juro.2014.06.083. Epub 2014 Jul 1.
[Malignant melanoma of the urinary bladder].
Otto T, Barski D, Bug R.
Urologe A. 2017 Jul;56(7):861-863. doi: 10.1007/s00120-017-0421-5.
Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma.
Zhang Q, Wu J, Chen X, Zhao M, Zhang D, Gao F.
Biomed Res Int. 2021 Feb 2;2021:6949864. doi: 10.1155/2021/6949864. eCollection 2021.
A model of malignant urinary bladder tumor in rabbits.
Nemoto R, Mori H, Iwata K, Kato T, Harada M.
Tohoku J Exp Med. 1981 Jul;134(3):257-63. doi: 10.1620/tjem.134.257.
Malignant mesenchymoma of the bladder.
Terada Y, Saito I, Morohoshi T, Niijima T.
Cancer. 1987 Aug 15;60(4):858-63. doi: 10.1002/1097-0142(19870815)60:4<858::aid-cncr2820600423>3.0.co;2-l.
Imaging of bladder cancer.
Zhang J, Gerst S, Lefkowitz RA, Bach A.
Radiol Clin North Am. 2007 Jan;45(1):183-205. doi: 10.1016/j.rcl.2006.10.005.
Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
Gakis G.
Eur Urol Focus. 2020 Jul 15;6(4):632-638. doi: 10.1016/j.euf.2020.01.007. Epub 2020 Jan 25.
